Adjunctive Aripiprazole in the Treatment of Risperidone-Induced Hyperprolactinemia
Condition(s):SchizophreniaLast Updated:December 17, 2013Unknown status
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:December 17, 2013Unknown status
Condition(s):Major Depressive DisorderLast Updated:May 21, 2014Completed
Condition(s):SchizophreniaLast Updated:December 4, 2018Completed
Condition(s):Major Depressive Disorder (MDD)Last Updated:December 22, 2021Terminated
Condition(s):Pediatric Bipolar DisorderLast Updated:April 6, 2012Terminated
Condition(s):SchizophreniaLast Updated:February 16, 2015Completed
Condition(s):Bipolar DisorderLast Updated:January 7, 2015Completed
Condition(s):SchizophreniaLast Updated:March 17, 2017Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:November 8, 2013Completed
Condition(s):Schizophrenia; Mental Disorder; Nervous System DiseasesLast Updated:July 1, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.